Douglass Chapman

3.7k total citations
62 papers, 2.7k citations indexed

About

Douglass Chapman is a scholar working on Surgery, Epidemiology and Rheumatology. According to data from OpenAlex, Douglass Chapman has authored 62 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 16 papers in Epidemiology and 15 papers in Rheumatology. Recurrent topics in Douglass Chapman's work include HIV Research and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Douglass Chapman is often cited by papers focused on HIV Research and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Douglass Chapman collaborates with scholars based in United States, United Kingdom and Canada. Douglass Chapman's co-authors include Donna Niedzwiecki, David P. Kelsen, Stephen C. Rubin, William J. Hoskins, R T Heelan, V. Vinciguerra, Murray F. Brennan, Charles N. Cornell, B. Carbone and Brendan M. Patterson and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Douglass Chapman

59 papers receiving 2.6k citations

Peers

Douglass Chapman
Rachel I. Gafni United States
Farid Boulad United States
Jeffrey Goldstein United States
Edwina J. Popek United States
David I. Kutler United States
Patrick J. Buckley United States
Josef Haas Austria
Rachel I. Gafni United States
Douglass Chapman
Citations per year, relative to Douglass Chapman Douglass Chapman (= 1×) peers Rachel I. Gafni

Countries citing papers authored by Douglass Chapman

Since Specialization
Citations

This map shows the geographic impact of Douglass Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglass Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglass Chapman more than expected).

Fields of papers citing papers by Douglass Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglass Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglass Chapman. The network helps show where Douglass Chapman may publish in the future.

Co-authorship network of co-authors of Douglass Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglass Chapman. A scholar is included among the top collaborators of Douglass Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglass Chapman. Douglass Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conaghan, Philip G., Mikkel Østergaard, O. Troum, et al.. (2019). Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 214–214. 21 indexed citations
2.
Surdo, Matteo, Claudia Alteri, María C. Puertas, et al.. (2014). Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029. Clinical Microbiology and Infection. 21(1). 103.e1–103.e6. 7 indexed citations
3.
Swenson, Luke C., Theresa Mo, Winnie Dong, et al.. (2011). Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc. Clinical Infectious Diseases. 53(7). 732–742. 79 indexed citations
4.
Segal, Allen T., Eli O. Meltzer, Richard F. Lockey, et al.. (2003). Once-Daily Cetirizine Is Safe and Effective for Children with Allergic Rhinitis with and without Intermittent Asthma. Pediatric Asthma Allergy & Immunology. 16(4). 265–274. 5 indexed citations
5.
Simons, F. Estelle R., et al.. (2003). Safety of cetirizine in infants 6 to 11 months of age: A randomized, double-blind, placebo-controlled study. Journal of Allergy and Clinical Immunology. 111(6). 1244–1248. 42 indexed citations
6.
Day, James H., Maureen P. Briscoe, Elizabeth Rafeiro, Douglass Chapman, & Benjamin Krämer. (2001). Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system. Annals of Allergy Asthma & Immunology. 87(6). 474–481. 47 indexed citations
7.
Hoehn‐Saric, Rudolf, Philip T. Ninan, Donald W. Black, et al.. (2000). Multicenter Double-blind Comparison of Sertraline and Desipramine for Concurrent Obsessive-Compulsive and Major Depressive Disorders. Archives of General Psychiatry. 57(1). 76–76. 91 indexed citations
8.
Newman, Elliot, et al.. (1996). The effect of blood transfusion on tumor growth in sarcoma-bearing rats. Annals of Surgical Oncology. 3(1). 74–79. 1 indexed citations
9.
Leibel, Steven A., Ruth Heimann, Gerald J. Kutcher, et al.. (1994). Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation study. International Journal of Radiation Oncology*Biology*Physics. 28(1). 55–65. 150 indexed citations
10.
Kemeny, Nancy E., John A. Conti, Elin R. Sigurdson, et al.. (1993). A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin.A potential adjuvant program after resection of colorectal hepatic metastases. Cancer. 71(6). 1964–1971. 45 indexed citations
11.
Davidson, Susan A., Stephen C. Rubin, Borys Mychalczak, et al.. (1993). Limited-Field Radiotherapy as Salvage Treatment of Localized Persistent or Recurrent Epithelial Ovarian Cancer. Gynecologic Oncology. 51(3). 349–354. 12 indexed citations
12.
Niedt, George, Patricia L. Myskowski, Carlos Urmacher, et al.. (1992). Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Human Pathology. 23(12). 1419–1426. 7 indexed citations
13.
Kemeny, Nancy E., Donna Niedzwiecki, Douglass Chapman, et al.. (1990). Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 8(2). 313–318. 85 indexed citations
14.
Straus, David J., Jeffrey J. Gaynor, Jane Myers, et al.. (1990). Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.. Journal of Clinical Oncology. 8(7). 1173–1186. 125 indexed citations
15.
Kelsen, David P., Bruce D. Minsky, M. Smith, et al.. (1990). Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.. Journal of Clinical Oncology. 8(8). 1352–1361. 119 indexed citations
16.
Reichman, Bonnie, Maurie Markman, Thomas B. Hakes, et al.. (1989). Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.. Journal of Clinical Oncology. 7(9). 1327–1332. 68 indexed citations
17.
Schneider, Andrew M., et al.. (1989). Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma. Cancer. 64(11). 2203–2206. 7 indexed citations
18.
Nanus, David M., David P. Kelsen, Donna Niedzwiecki, et al.. (1989). Flow cytometry as a predictive indicator in patients with operable gastric cancer.. Journal of Clinical Oncology. 7(8). 1105–1112. 53 indexed citations
19.
Gaynor, Jeffrey J., Douglass Chapman, Claudia Little, et al.. (1988). A Cause-Specific Hazard Rate Analysis of Prognostic Factors Among 199 Adults With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 6(9). 1522–1522. 1 indexed citations
20.
Gaynor, Jeffrey J., Douglass Chapman, C. Little, et al.. (1988). A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.. Journal of Clinical Oncology. 6(6). 1014–1030. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026